Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Pathways: Human Leukocyte Antigen G (HLA-G)
Giuseppe Curigliano, Carmen Criscitiello, Lucia Gelao, et al.
Clinical Cancer Research (2013) Vol. 19, Iss. 20, pp. 5564-5571
Closed Access | Times Cited: 120

Showing 1-25 of 120 citing articles:

Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy
Bin Wang, Qin Zhao, Yuyu Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 217
Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
Muhammad Zaeem Noman, Meriem Hasmim, Audrey Lequeux, et al.
Cells (2019) Vol. 8, Iss. 9, pp. 1083-1083
Open Access | Times Cited: 178
Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy
Aifen Lin, Wei‐Hua Yan
Molecular Medicine (2015) Vol. 21, Iss. 1, pp. 782-791
Open Access | Times Cited: 120
BRAFV600E in Papillary Thyroid Carcinoma Is Associated with Increased Programmed Death Ligand 1 Expression and Suppressive Immune Cell Infiltration
Trevor E. Angell, Melissa G. Lechner, Julie K. Jang, et al.
Thyroid (2014) Vol. 24, Iss. 9, pp. 1385-1393
Open Access | Times Cited: 119
HLA-G as a Tolerogenic Molecule in Transplantation and Pregnancy
Vera Rebmann, Fabiola da Silva Nardi, Bettina Wagner, et al.
Journal of Immunology Research (2014) Vol. 2014, pp. 1-16
Open Access | Times Cited: 112
Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices
Moreno Di Marco, Heiko Schuster, Linus Backert, et al.
The Journal of Immunology (2017) Vol. 199, Iss. 8, pp. 2639-2651
Open Access | Times Cited: 100
HLA and proteasome expression body map
Sebastian Boegel, Martin Löwer, Thomas Bukur, et al.
BMC Medical Genomics (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 100
Role of hypoxia in the tumor microenvironment and targeted therapy
Gaoqi Chen, Kaiwen Wu, Hao Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 60
BiTE‐Secreting CAR‐γδT as a Dual Targeting Strategy for the Treatment of Solid Tumors
Shi‐Wei Huang, Chih‐Ming Pan, Yu‐Chuan Lin, et al.
Advanced Science (2023) Vol. 10, Iss. 17
Open Access | Times Cited: 23
The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients
Lisa König, Sabine Kasimir‐Bauer, Oliver Hoffmann, et al.
Human Immunology (2016) Vol. 77, Iss. 9, pp. 791-799
Closed Access | Times Cited: 76
New insights into HLA‐G mediated tolerance
Giada Amodio, Rafael Sales de Albuquerque, Silvia Gregori
Tissue Antigens (2014) Vol. 84, Iss. 3, pp. 255-263
Closed Access | Times Cited: 67
HLA-G expression levels influence the tolerogenic activity of human DC-10
Giada Amodio, Michela Comi, Daniela Tomasoni, et al.
Haematologica (2015) Vol. 100, Iss. 4, pp. 548-557
Open Access | Times Cited: 65
MHC/HLA Class I Loss in Cancer Cells
Federico Garrido
Advances in experimental medicine and biology (2019), pp. 15-78
Closed Access | Times Cited: 65
CD8+PD-1–ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-G
Clément Dumont, Alix Jacquier, Jérôme Verine, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 10, pp. 1619-1632
Open Access | Times Cited: 62
Mesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients
Ruijuan Cheng, Anji Xiong, Yanhong Li, et al.
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 59
Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors
Chia‐Ing Jan, Shi‐Wei Huang, Peter Canoll, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 10, pp. e003050-e003050
Open Access | Times Cited: 52
Immunologic aspects of preeclampsia
Henri Boulanger, S. Bounan, Amel Mahdhi, et al.
AJOG Global Reports (2024) Vol. 4, Iss. 1, pp. 100321-100321
Open Access | Times Cited: 7
Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance
Jiali Yu, Yijian Yan, Shasha Li, et al.
Cell (2024) Vol. 187, Iss. 17, pp. 4713-4732.e19
Open Access | Times Cited: 6
The Potential of HLA-G-Bearing Extracellular Vesicles as a Future Element in HLA-G Immune Biology
Vera Rebmann, Lisa König, Fabiola da Silva Nardi, et al.
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 58
HLA-G Orchestrates the Early Interaction of Human Trophoblasts with the Maternal Niche
Silvia Gregori, Giada Amodio, Federica Quattrone, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 54
Spatial immunoprofiling of the intratumoral and peritumoral tissue of renal cell carcinoma patients
Oscar Brück, Moon Hee Lee, Riku Turkki, et al.
Modern Pathology (2021) Vol. 34, Iss. 12, pp. 2229-2241
Open Access | Times Cited: 32
Hypoxic Modulation of HLA-G Expression through the Metabolic Sensor HIF-1 in Human Cancer Cells
Marica Garziera, Lucia Scarabel, Giuseppe Toffoli
Journal of Immunology Research (2017) Vol. 2017, pp. 1-13
Open Access | Times Cited: 46
Breast cancer circulating biomarkers: advantages, drawbacks, and new insights
Andrea Ravelli, James M. Reuben, Francesco Lanza, et al.
Tumor Biology (2015) Vol. 36, Iss. 9, pp. 6653-6665
Closed Access | Times Cited: 42
Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation
Ion G. Motofei
Seminars in Cancer Biology (2021) Vol. 86, pp. 600-615
Closed Access | Times Cited: 29
Circulating Biomarkers in Malignant Melanoma
Estíbaliz Alegre, Miguel Sammamed, Sara Fernández-Landázuri, et al.
Advances in clinical chemistry (2015), pp. 47-89
Closed Access | Times Cited: 38
Page 1 - Next Page

Scroll to top